Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin in Biopsy Scar Minimization
NCT05478551Phase 3Active, not recruiting
- Sponsor
- Henry Ford Health
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of neuronox in scar, sponsored by Henry Ford Health. Started Jun 2022; status: active, not recruiting.
02
Drugs
neuronox
03
Conditions
scar
Beyond the preview
Go deeper on NCT05478551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05478551.